HistCite - Trojanowski w/citing papers

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
601	21938 Planel E, Krishnamurthy P, Miyasaka T, Liu L, Herman M, et al. Anesthesia-Induced Hyperphosphorylation Detaches 3-Repeat Tau from Microtubules without Affecting Their Stability In Vivo JOURNAL OF NEUROSCIENCE. 2008 NOV 26; 28 (48): 12798-12807	7	10	51	79
602	22372 Neumann M Molecular Neuropathology of TDP-43 Proteinopathies INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2009 JAN; 10 (1): 232-246	19	21	51	64
603	23541 Rademakers R, Rovelet-Lecrux A Recent insights into the molecular genetics of dementia TRENDS IN NEUROSCIENCES. 2009 AUG; 32 (8): 451-461	6	10	51	117
604	25545 Ashe KH, Zahs KR Probing the Biology of Alzheimer's Disease in Mice NEURON. 2010 JUN 10; 66 (5): 631-645	1	15	51	198
605	25678 Buratti E, Baralle FE The multiple roles of TDP-43 in pre-mRNA processing and gene expression regulation RNA BIOLOGY. 2010 JUL-AUG; 7 (4): 420-429	1	1	51	107
606	25821 Siebert H, Kahle PJ, Kramer ML, Isik T, Schluter OM, et al. Over-expression of alpha-synuclein in the nervous system enhances axonal degeneration after peripheral nerve lesion in a transgenic mouse strain JOURNAL OF NEUROCHEMISTRY. 2010 AUG; 114 (4): 1007-1018	0	0	51	74
607	26157 Schwab C, Klegeris A, McGeer PL Inflammation in transgenic mouse models of neurodegenerative disorders BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2010 OCT; 1802 (10): 889-902	1	4	51	213
608	26307 Buttner S, Delay C, Franssens V, Bammens T, Ruli D, et al. Synphilin-1 Enhances alpha-Synuclein Aggregation in Yeast and Contributes to Cellular Stress and Cell Death in a Sir2-Dependent Manner PLOS ONE. 2010 OCT 27; 5 (10): Art. No. e13700	0	0	51	80
609	26505 Courtney E, Kornfeld S, Janitz K, Janitz M Transcriptome profiling in neurodegenerative disease JOURNAL OF NEUROSCIENCE METHODS. 2010 NOV 30; 193 (2): 189-202	1	1	51	159
610	26552 Grossman M Biomarkers in frontotemporal lobar degeneration CURRENT OPINION IN NEUROLOGY. 2010 DEC; 23 (6): 643-648	0	0	51	59
#	Date / Author / Journal	LCS	GCS	LCR	CR
611	27009 Bai Q, Burton EA Zebrafish models of Tauopathy BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2011 MAR; 1812 (3): 353-363	0	0	51	127
612	7853 Goedert M, Ghetti B, Spillantini MG Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) - Their relevance for understanding the neurogenerative process MOLECULAR BASIS OF DEMENTIA. 2000; 920: 74-83	17	26	50	66
613	8077 Gordon-Krajcer W, Yang LS, Ksiezak-Reding H Conformation of paired helical filaments blocks dephosphorylation of epitopes shared with fetal tau except Ser199/202 and Ser202/Thr205 BRAIN RESEARCH. 2000 FEB 21; 856 (1-2): 163-175	22	24	50	65
614	9923 Kotzbauer PT, Trojanowski JQ, Lee VMY Lewy body pathology in Alzheimer's disease JOURNAL OF MOLECULAR NEUROSCIENCE. 2001 OCT; 17 (2): 225-232	56	56	50	80
615	11029 Mattson MP, Chan SL, Duan WZ Modification of brain aging and neurodegenerative disorders by genes, diet, and behavior PHYSIOLOGICAL REVIEWS. 2002 JUL; 82 (3): 637-672	26	169	50	399
616	11103 Ellison D Classifying the medulloblastoma: insights from morphology and molecular genetics NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2002 AUG; 28 (4): 257-282	27	91	50	226
617	11922 Majoor-Krakauer D, Willems PJ, Hofman A Genetic epidemiology of amyotrophic lateral sclerosis CLINICAL GENETICS. 2003 FEB; 63 (2): 83-101	15	56	50	272
618	12167 Waldmeier PC Prospects for antiapoptotic drug therapy of neurodegenerative diseases PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. 2003 APR; 27 (2): 303-321	9	46	50	202
619	12499 Murray IVJ, Giasson BI, Quinn SM, Koppaka V, Axelsen PH, et al. Role of alpha-synuclein carboxy-terminus on fibril formation in vitro BIOCHEMISTRY. 2003 JUL 22; 42 (28): 8530-8540	95	95	50	59
620	14681 Lowe R, Pountney DL, Jensen PH, Gai WP, Voelcker NH Calcium(II) selectively induces alpha-synuclein annular oligomers via interaction with the C-terminal domain PROTEIN SCIENCE. 2004 DEC; 13 (12): 3245-3252	25	39	50	62
#	Date / Author / Journal	LCS	GCS	LCR	CR
621	14952 Andreadis A Tau gene alternative splicing: expression patterns, regulation and modulation of function in normal brain and neurodegenerative diseases BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2005 JAN 3; 1739 (2-3): 91-103	38	64	50	108
622	15794 Kanthasamy AG, Kitazawa M, Kanthasamy A, Anantharam V Dieldrin-induced neurotoxicity: Relevance to Parkinson's disease pathogenesis NEUROTOXICOLOGY. 2005 AUG; 26 (4): 701-719	3	40	50	247
623	16115 Paleologou KE, Irvine GB, El-Agnaf OMA alpha-Synuclein aggregation in neurodegenerative diseases and its inhibition as a potential therapeutic strategy BIOCHEMICAL SOCIETY TRANSACTIONS. 2005 NOV; 33: 1106-1110	15	16	50	65
624	16146 Szczygielski J, Mautes A, Steudel WI, Falkai P, Bayer TA, et al. Traumatic brain injury: cause or risk of Alzheimer's disease? A review of experimental studies JOURNAL OF NEURAL TRANSMISSION. 2005 NOV; 112 (11): 1547-1564	7	18	50	126
625	17443 Buneeva OA, Medvedev AE Ubiquitin-protein ligase parkin and its role in the development of Parkinson's disease BIOCHEMISTRY-MOSCOW. 2006 AUG; 71 (8): 851-860	0	0	50	104
626	17869 Julien JP, Kriz J Transgenic mouse models of amyotrophic lateral sclerosis BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2006 NOV-DEC; 1762 (11-12): 1013-1024	16	37	50	129
627	18128 Ozansoy M, Basak AN Tauopathies: A distinct class of neurodegenerative diseases BALKAN JOURNAL OF MEDICAL GENETICS. 2007; 10 (2): 3-14	0	0	50	65
628	18775 Jellinger KA The enigma of vascular cognitive disorder and vascular dementia ACTA NEUROPATHOLOGICA. 2007 APR; 113 (4): 349-388	13	43	50	551
629	19168 Barry DM, Millecamps S, Julien JP, Garcia ML New movements in neurofilament transport, turnover and disease EXPERIMENTAL CELL RESEARCH. 2007 JUN 10; 313 (10): 2110-2120	4	18	50	104
630	19473 Leroy K, Bretteville A, Schindowski K, Gilissen E, Authelet M, et al. Early axonopathy preceding neurofibrillary tangles in mutant tau transgenic mice AMERICAN JOURNAL OF PATHOLOGY. 2007 SEP; 171 (3): 976-992	21	23	50	72
#	Date / Author / Journal	LCS	GCS	LCR	CR
631	19929 Pankratz N, Foroud T Genetics of Parkinson disease GENETICS IN MEDICINE. 2007 DEC; 9 (12): 801-811	2	21	50	220
632	20295 Rohrer JD, Knight WD, Warren JE, Fox NC, Rossor MN, et al. Word-finding difficulty: a clinical analysis of the progressive aphasias BRAIN. 2008 JAN; 131: 8-38	8	17	50	215
633	21667 Fasano M, Alberio T, Lopiano L Peripheral biomarkers of Parkinson's disease as early reporters of central neurodegeneration BIOMARKERS IN MEDICINE. 2008 OCT; 2 (5): 465-478	1	6	50	135
634	22054 Zhou JH, Yu QM, Zou T Alternative splicing of exon 10 in the tau gene as a target for treatment of tauopathies BMC NEUROSCIENCE. 2008 DEC 3; 9: Art. No. S10	0	2	50	92
635	22671 Ludolph AC, Kassubek J, Landwehrmeyer BG, Mandelkow E, Mandelkow EM, et al. Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options EUROPEAN JOURNAL OF NEUROLOGY. 2009 MAR; 16 (3): 297-309	11	17	50	84
636	23175 Golovko MY, Barcelo-Coblijn G, Castagnet PI, Austin S, Combs CK, et al. The role of alpha-synuclein in brain lipid metabolism: a downstream impact on brain inflammatory response MOLECULAR AND CELLULAR BIOCHEMISTRY. 2009 JUN; 326 (1-2): 55-66	6	8	50	153
637	23242 Yotsumoto K, Saito T, Asada A, Oikawa T, Kimura T, et al. Effect of Pin1 or Microtubule Binding on Dephosphorylation of FTDP-17 Mutant Tau JOURNAL OF BIOLOGICAL CHEMISTRY. 2009 JUN 19; 284 (25): 16840-16847	1	2	50	63
638	23857 Paris I, Lozano J, Perez-Pastene C, Munoz P, Segura-Aguilar J Molecular and Neurochemical Mechanisms in PD Pathogenesis NEUROTOXICITY RESEARCH. 2009 OCT; 16 (3): 271-279	2	2	50	96
639	24139 Mistur R, Mosconi L, De Santi S, Guzman M, Li Y, et al. Current Challenges for the Early Detection of Alzheimer's Disease: Brain Imaging and CSF Studies JOURNAL OF CLINICAL NEUROLOGY. 2009 DEC; 5 (4): 153-166	1	3	50	153
640	25497 Obeso JA, Rodriguez-Oroz MC, Goetz CG, Marin C, Kordower JH, et al. Missing pieces in the Parkinson's disease puzzle NATURE MEDICINE. 2010 JUN; 16 (6): 653-661	3	7	50	126
#	Date / Author / Journal	LCS	GCS	LCR	CR
641	25571 Gundersen V Protein aggregation in Parkinson's disease ACTA NEUROLOGICA SCANDINAVICA. 2010 JUL; 122: 82-87	0	0	50	79
642	25619 Feng LR, Federoff HJ, Vicini S, Maguire-Zeiss KA alpha-Synuclein mediates alterations in membrane conductance: a potential role for alpha-synuclein oligomers in cell vulnerability EUROPEAN JOURNAL OF NEUROSCIENCE. 2010 JUL; 32 (1): 10-17	0	0	50	68
643	25983 Dolan PJ, Johnson GVW The role of tau kinases in Alzheimer's disease CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT. 2010 SEP; 13 (5): 595-603	0	0	50	109
644	26147 Geser F, Robinson JL, Malunda JA, Xie SX, Clark CM, et al. Pathological 43-kDa Transactivation Response DNA-Binding Protein in Older Adults With and Without Severe Mental Illness ARCHIVES OF NEUROLOGY. 2010 OCT; 67 (10): 1238-1250	0	0	50	55
645	26640 Colodner KJ, Feany MB Glial Fibrillary Tangles and JAK/STAT-Mediated Glial and Neuronal Cell Death in a Drosophila Model of Glial Tauopathy JOURNAL OF NEUROSCIENCE. 2010 DEC 1; 30 (48): 16102-16113	0	0	50	93
646	6553 Hanger DP, Betts JC, Loviny TLF, Blackstock WP, Anderton BH New phosphorylation sites identified in hyperphosphorylated tau (paired helical filament-tau) from Alzheimer's disease brain using nanoelectrospray mass spectrometry JOURNAL OF NEUROCHEMISTRY. 1998 DEC; 71 (6): 2465-2476	124	173	49	69
647	7665 Spittaels K, Van den Haute C, Van Dorpe J, Bruynseels K, Vandezande K, et al. Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein AMERICAN JOURNAL OF PATHOLOGY. 1999 DEC; 155 (6): 2153-2165	173	197	49	68
648	10056 Perrin RJ, Woods WS, Clayton DF, George JM Exposure to long chain polyunsaturated fatty acids triggers rapid multimerization of synucleins JOURNAL OF BIOLOGICAL CHEMISTRY. 2001 NOV 9; 276 (45): 41958-41962	88	103	49	71
649	10286 Jellinger KA Recent developments in the pathology of Parkinson's disease JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2002; (62): 347-376	0	53	49	169
650	11147 Weller RE, Steele GE, Kaas JH Pulvinar and other subcortical connections of dorsolateral visual cortex in monkeys JOURNAL OF COMPARATIVE NEUROLOGY. 2002 AUG 26; 450 (3): 215-240	1	15	49	283
#	Date / Author / Journal	LCS	GCS	LCR	CR
651	11345 Skipper L, Farrer M Parkinson's genetics: Molecular insights for the new millennium NEUROTOXICOLOGY. 2002 OCT; 23 (4-5): 503-514	6	16	49	134
652	12151 Hardy J, Cookson MR, Singleton A Genes and parkinsonism LANCET NEUROLOGY. 2003 APR; 2 (4): 221-228	32	66	49	102
653	12278 Destee A Neuroprotection and neurodegenerative parkinsonian syndromes. REVUE NEUROLOGIQUE. 2003 MAY; 159 (5): S93-S104	0	0	49	156
654	12767 Di Rosa G, Puzzo D, Sant'Angelo A, Trinchese F, Arancio O alpha-synuclein: between synaptic function and dysfunction HISTOLOGY AND HISTOPATHOLOGY. 2003 OCT; 18 (4): 1257-1266	9	12	49	102
655	13475 Wersinger C, Vernier P, Sidhu A Trypsin disrupts the trafficking of the human dopamine transporter by alpha-synuclein and its A30P mutant BIOCHEMISTRY. 2004 FEB 10; 43 (5): 1242-1253	11	19	49	63
656	14046 Pountney DL, Lowe R, Quilty M, Vickers JC, Voelcker NH, et al. Annular alpha-synuclein species from purified multiple system atrophy inclusions JOURNAL OF NEUROCHEMISTRY. 2004 JUL; 90 (2): 502-512	18	24	49	59
657	14925 Harrison PJ, Weinberger DR Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence MOLECULAR PSYCHIATRY. 2005 JAN; 10 (1): 40-68	85	632	49	392
658	15010 Wenning GK, Jellinger KA The role of alpha-synuclein in the pathogenesis of multiple system atrophy ACTA NEUROPATHOLOGICA. 2005 FEB; 109 (2): 129-140	24	27	49	101
659	16443 Coimbra A, Williams DS, Hostetler ED The role of MRI and PET/SPECT in Alzheimer's disease CURRENT TOPICS IN MEDICINAL CHEMISTRY. 2006; 6 (6): 629-647	4	13	49	171
660	17185 McNaught KSP, Jackson T, JnoBaptiste R, Kapustin A, Olanow CW Proteasomal dysfunction in sporadic Parkinson's disease NEUROLOGY. 2006 MAY 23; 66 (10): S37-S49	9	21	49	104
#	Date / Author / Journal	LCS	GCS	LCR	CR
661	17491 Wakabayashi K, Takahashi H Cellular pathology in multiple system atrophy NEUROPATHOLOGY. 2006 AUG; 26 (4): 338-345	21	28	49	91
662	19011 Zibaee S, Makin OS, Goedert M, Serpell LC A simple algorithm locates beta-strands in the amyloid fibril core of alpha-synuclein, A beta, and tau using the amino acid sequence alone PROTEIN SCIENCE. 2007 MAY; 16 (5): 906-918	6	23	49	112
663	19823 Mackenzie IRA, Rademakers R The molecular genetics and neuropathology of frontotemporal lobar degeneration: recent developments NEUROGENETICS. 2007 NOV; 8 (4): 237-248	20	21	49	85
664	20422 Mocanu MM, Nissen A, Eckermann K, Khlistunova I, Biernat J, et al. The potential for beta-structure in the repeat domain of Tau protein determines aggregation, synaptic decay, neuronal loss, and coassembly with endogenous Tau in inducible mouse models of tauopathy JOURNAL OF NEUROSCIENCE. 2008 JAN 16; 28 (3): 737-748	37	47	49	69
665	21448 Vosler PS, Brennan CS, Chen J Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration MOLECULAR NEUROBIOLOGY. 2008 AUG; 38 (1): 78-100	4	36	49	305
666	22019 de Bont JM, Packer RJ, Michiels EM, den Boer ML, Pieters R Biological background of pediatric medulloblastoma and ependymoma: A review from a translational research perspective NEURO-ONCOLOGY. 2008 DEC; 10 (6): 1040-1060	3	14	49	246
667	22063 Zhang L, Zhang CY, Zhu YY, Cai Q, Chan P, et al. Semi-quantitative analysis of alpha-synuclein in subcellular pools of rat brain neurons: An immunogold electron microscopic study using a C- terminal specific monoclonal antibody BRAIN RESEARCH. 2008 DEC 9; 1244: 40-52	8	12	49	62
668	22731 Hanger DP, Anderton BH, Noble W Tau phosphorylation: the therapeutic challenge for neurodegenerative disease TRENDS IN MOLECULAR MEDICINE. 2009 MAR; 15 (3): 112-119	28	40	49	72
669	22851 Koren J, Jinwal UK, Lee DC, Jones JR, Shults CL, et al. Chaperone signalling complexes in Alzheimer's disease JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. 2009 APR; 13 (4): 619-630	3	7	49	133
670	23060 Zhou WB, Gallagher A, Hong DP, Long CM, Fink AL, et al. At Low Concentrations, 3,4-Dihydroxyphenylacetic Acid (DOPAC) Binds Non-Covalently to alpha-Synuclein and Prevents Its Fibrillation JOURNAL OF MOLECULAR BIOLOGY. 2009 MAY 8; 388 (3): 597-610	4	7	49	87
#	Date / Author / Journal	LCS	GCS	LCR	CR
671	23152 Huang A, Stultz CM Finding order within disorder: elucidating the structure of proteins associated with neurodegenerative disease FUTURE MEDICINAL CHEMISTRY. 2009 JUN; 1 (3): 467-482	0	2	49	125
672	23236 Kowalska A The genetics of dementias. Part 1: Molecular basis of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ. 2009 JUN 15; 63: 278-286	0	2	49	75
673	23806 McCormack AL, Di Monte DA Enhanced alpha-Synuclein Expression in Human Neurodegenerative Diseases: Pathogenetic and Therapeutic Implications CURRENT PROTEIN & PEPTIDE SCIENCE. 2009 OCT; 10 (5): 476-482	1	2	49	73
674	24754 Arawaka S, Machiya Y, Kato T Heat Shock Proteins as Suppressors of Accumulation of Toxic Prefibrillar Intermediates and Misfolded Proteins in Neurodegenerative Diseases CURRENT PHARMACEUTICAL BIOTECHNOLOGY. 2010 FEB; 11 (2): 158-166	0	2	49	95
675	25575 Urwin H, Josephs KA, Rohrer JD, Mackenzie IR, Neumann M, et al. FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration ACTA NEUROPATHOLOGICA. 2010 JUL; 120 (1): 33-41	7	7	49	58
676	26532 Viana RJS, Fonseca MB, Ramalho RM, Nunes AF, Rodrigues CMP Organelle Stress Sensors and Cell Death Mechanisms in Neurodegenerative Diseases CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2010 DEC; 9 (6): 679-692	0	0	49	200
677	26564 Vanhelmont T, Vandebroek T, De Vos A, Terwel D, Lemaire K, et al. Serine-409 phosphorylation and oxidative damage define aggregation of human protein tau in yeast FEMS YEAST RESEARCH. 2010 DEC; 10 (8): 992-1005	0	1	49	76
678	26905 Prasad K, Tarasewicz E, Strickland PA, O'Neill M, Mitchell SN, et al. Biochemical and morphological consequences of human alpha-synuclein expression in a mouse alpha-synuclein null background EUROPEAN JOURNAL OF NEUROSCIENCE. 2011 FEB; 33 (4): 642-656	0	0	49	83
679	3641 GOEDERT M MOLECULAR DISSECTION OF THE NEUROFIBRILLARY LESIONS OF ALZHEIMERS- DISEASE ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH. 1995 MAR; 45-1 (3A): 403-409	0	9	48	84
680	5839 Zheng-Fischhofer QY, Biernat J, Mandelkow EM, Illenberger S, Godemann R, et al. Sequential phosphorylation of Tau by glycogen synthase kinase-3 beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer- specific epitope of antibody AT100 and requires a paired-helical- filament-like conformation EUROPEAN JOURNAL OF BIOCHEMISTRY. 1998 MAR 15; 252 (3): 542-552	117	166	48	78
#	Date / Author / Journal	LCS	GCS	LCR	CR
681	6049 Illenberger S, Zheng-Fischhofer QY, Preuss U, Stamer K, Baumann K, et al. The endogenous and cell cycle-dependent phosphorylation of tau protein in living cells: Implications for Alzheimer's disease MOLECULAR BIOLOGY OF THE CELL. 1998 JUN; 9 (6): 1495-1512	101	159	48	102
682	7380 Kim D, Su J, Cotman CW Sequence of neurodegeneration and accumulation of phosphorylated tau in cultured neurons after okadaic acid treatment BRAIN RESEARCH. 1999 AUG 28; 839 (2): 253-262	24	39	48	74
683	9075 Lowe J, Mayer J, Landon M, Layfield R Ubiquitin and the molecular pathology of neurodegenerative diseases NEUROPATHOLOGY AND GENETICS OF DEMENTIA. 2001; 487: 169-186	10	27	48	144
684	9127 El-Agnaf OMA, Irvine GB Aggregation and properties of alpha-synuclein and related proteins SPECTROSCOPY-AN INTERNATIONAL JOURNAL. 2001; 15 (3-4): 141-150	0	0	48	59
685	9886 Neumann M, Schulz-Schaeffer W, Crowther RA, Smith MJ, Spillantini MG, et al. Pick's disease associated with the novel Tau gene mutation K369I ANNALS OF NEUROLOGY. 2001 OCT; 50 (4): 503-513	60	61	48	56
686	9961 Kins S, Crameri A, Evans DRH, Hemmings BA, Nitsch RM, et al. Reduced protein phosphatase 2A activity induces hyperphosphorylation and altered compartmentalization of tau in transgenic mice JOURNAL OF BIOLOGICAL CHEMISTRY. 2001 OCT 12; 276 (41): 38193-38200	63	85	48	79
687	10119 Giasson BI, Duda JE, Forman MS, Lee VMY, Trojanowski JQ Prominent perikaryal expression of alpha- and beta-synuclein in neurons of dorsal root ganglion and in medullary neurons EXPERIMENTAL NEUROLOGY. 2001 DEC; 172 (2): 354-362	31	31	48	62
688	10199 Jellinger KA Recent developments in the pathology of Parkinson's disease AGEING AND DEMENTIA CURRENT AND FUTURE CONCEPTS. 2002; : 347-376	0	0	48	167
689	10888 Greicius MD, Geschwind MD, Miller BL Presenile dementia syndromes: an update on taxonomy and diagnosis JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2002 JUN; 72 (6): 691-700	6	23	48	170
690	11116 Higuchi M, Ishihara T, Zhang B, Hong M, Andreadis A, et al. Transgenic mouse model of tauopathies with glial pathology and nervous system degeneration NEURON. 2002 AUG 1; 35 (3): 433-446	64	64	48	65
#	Date / Author / Journal	LCS	GCS	LCR	CR
691	11582 Green AJE Cerebrospinal fluid brain-derived proteins in the diagnosis of Alzheimer's disease and Creutzfeldt-Jakob disease NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2002 DEC; 28 (6): 427-440	5	24	48	135
692	11651 McNaught KS, Olanow CW Proteolytic stress: A unifying concept for the etiopathogenesis of Parkinson's disease ANNALS OF NEUROLOGY. 2003; 53: S73-S84	37	77	48	94
693	11722 Spillantini MG Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 INTERNATIONAL SEMINAR ON NUCLEAR WAR AND PLANETARY EMERGENCIES - 27TH SESSION. 2003; : 647-659	0	0	48	55
694	11965 Liou AKF, Clark RS, Henshall DC, Yin XM, Chen J To die or not to die for neurons in ischemia, traumatic brain injury and epilepsy: a review on the stress-activated signaling pathways and apoptotic pathways PROGRESS IN NEUROBIOLOGY. 2003 FEB; 69 (2): 103-142	9	98	48	497
695	13604 Lee VMY, Giasson BI, Trojanowski JQ More than just two peas in a pod: common amyloidogenic properties of tau and alpha-synuclein in neurodegenerative diseases TRENDS IN NEUROSCIENCES. 2004 MAR; 27 (3): 129-134	67	67	48	57
696	14003 Klucken J, Shin Y, Masliah E, Hyman BT, McLean PJ Hsp70 reduces alpha-synuclein aggregation and toxicity JOURNAL OF BIOLOGICAL CHEMISTRY. 2004 JUN 11; 279 (24): 25497-25502	113	139	48	69
697	14040 Rissman RA, Poon WW, Blurton-Jones M, Oddo S, Torp R, et al. Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology JOURNAL OF CLINICAL INVESTIGATION. 2004 JUL; 114 (1): 121-130	74	125	48	80
698	14337 Zhou Y, Gu GY, Goodlett DR, Zhang T, Pan C, et al. Analysis of alpha-synuclein-associated proteins by quantitative proteomics JOURNAL OF BIOLOGICAL CHEMISTRY. 2004 SEP 10; 279 (37): 39155-39164	39	72	48	77
699	14538 Fernagut PO, Chesselet MF Alpha-synuclein and transgenic mouse models NEUROBIOLOGY OF DISEASE. 2004 NOV; 17 (2): 123-130	49	59	48	69
700	15056 Cotman CW, Poon WW, Rissman RA, Blurton-Jones M The role of caspase cleavage of tau in Alzheimer disease neuropathology JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2005 FEB; 64 (2): 104-112	32	64	48	85

Date / Author / Journal

LCS

GCS

LCR

601

21938 Planel E, Krishnamurthy P, Miyasaka T, Liu L, Herman M, et al.

Anesthesia-Induced Hyperphosphorylation Detaches 3-Repeat Tau from Microtubules without Affecting Their Stability In Vivo

JOURNAL OF NEUROSCIENCE. 2008 NOV 26; 28 (48): 12798-12807

602

22372 Neumann M

Molecular Neuropathology of TDP-43 Proteinopathies

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2009 JAN; 10 (1): 232-246

603

23541 Rademakers R, Rovelet-Lecrux A

Recent insights into the molecular genetics of dementia

TRENDS IN NEUROSCIENCES. 2009 AUG; 32 (8): 451-461

117

604

25545 Ashe KH, Zahs KR

Probing the Biology of Alzheimer's Disease in Mice

NEURON. 2010 JUN 10; 66 (5): 631-645

198

605

25678 Buratti E, Baralle FE

The multiple roles of TDP-43 in pre-mRNA processing and gene expression regulation

RNA BIOLOGY. 2010 JUL-AUG; 7 (4): 420-429

107

606

25821 Siebert H, Kahle PJ, Kramer ML, Isik T, Schluter OM, et al.

Over-expression of alpha-synuclein in the nervous system enhances axonal degeneration after peripheral nerve lesion in a transgenic mouse strain

JOURNAL OF NEUROCHEMISTRY. 2010 AUG; 114 (4): 1007-1018

607

26157 Schwab C, Klegeris A, McGeer PL

Inflammation in transgenic mouse models of neurodegenerative disorders

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2010 OCT; 1802 (10): 889-902

213

608

26307 Buttner S, Delay C, Franssens V, Bammens T, Ruli D, et al.

Synphilin-1 Enhances alpha-Synuclein Aggregation in Yeast and Contributes to Cellular Stress and Cell Death in a Sir2-Dependent Manner

PLOS ONE. 2010 OCT 27; 5 (10): Art. No. e13700

609

26505 Courtney E, Kornfeld S, Janitz K, Janitz M

Transcriptome profiling in neurodegenerative disease

JOURNAL OF NEUROSCIENCE METHODS. 2010 NOV 30; 193 (2): 189-202

159

610

26552 Grossman M

Biomarkers in frontotemporal lobar degeneration

CURRENT OPINION IN NEUROLOGY. 2010 DEC; 23 (6): 643-648

Date / Author / Journal

LCS

GCS

LCR

611

27009 Bai Q, Burton EA

Zebrafish models of Tauopathy

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2011 MAR; 1812 (3): 353-363

127

612

7853 Goedert M, Ghetti B, Spillantini MG

Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) - Their relevance for understanding the neurogenerative process

MOLECULAR BASIS OF DEMENTIA. 2000; 920: 74-83

613

8077 Gordon-Krajcer W, Yang LS, Ksiezak-Reding H

Conformation of paired helical filaments blocks dephosphorylation of epitopes shared with fetal tau except Ser199/202 and Ser202/Thr205

BRAIN RESEARCH. 2000 FEB 21; 856 (1-2): 163-175

614

9923 Kotzbauer PT, Trojanowski JQ, Lee VMY

Lewy body pathology in Alzheimer's disease

JOURNAL OF MOLECULAR NEUROSCIENCE. 2001 OCT; 17 (2): 225-232

615

11029 Mattson MP, Chan SL, Duan WZ

Modification of brain aging and neurodegenerative disorders by genes, diet, and behavior

PHYSIOLOGICAL REVIEWS. 2002 JUL; 82 (3): 637-672

169

399

616

11103 Ellison D

Classifying the medulloblastoma: insights from morphology and molecular genetics

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2002 AUG; 28 (4): 257-282

226

617

11922 Majoor-Krakauer D, Willems PJ, Hofman A

Genetic epidemiology of amyotrophic lateral sclerosis

CLINICAL GENETICS. 2003 FEB; 63 (2): 83-101

272

618

12167 Waldmeier PC

Prospects for antiapoptotic drug therapy of neurodegenerative diseases

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. 2003 APR; 27 (2): 303-321

202

619

12499 Murray IVJ, Giasson BI, Quinn SM, Koppaka V, Axelsen PH, et al.

Role of alpha-synuclein carboxy-terminus on fibril formation in vitro

BIOCHEMISTRY. 2003 JUL 22; 42 (28): 8530-8540

620

14681 Lowe R, Pountney DL, Jensen PH, Gai WP, Voelcker NH

Calcium(II) selectively induces alpha-synuclein annular oligomers via interaction with the C-terminal domain

PROTEIN SCIENCE. 2004 DEC; 13 (12): 3245-3252

Date / Author / Journal

621

Tau gene alternative splicing: expression patterns, regulation and modulation of function in normal brain and neurodegenerative diseases

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2005 JAN 3; 1739 (2-3): 91-103

108

622

15794 Kanthasamy AG, Kitazawa M, Kanthasamy A, Anantharam V

Dieldrin-induced neurotoxicity: Relevance to Parkinson's disease pathogenesis

NEUROTOXICOLOGY. 2005 AUG; 26 (4): 701-719

247

623

16115 Paleologou KE, Irvine GB, El-Agnaf OMA

alpha-Synuclein aggregation in neurodegenerative diseases and its inhibition as a potential therapeutic strategy

BIOCHEMICAL SOCIETY TRANSACTIONS. 2005 NOV; 33: 1106-1110

624

16146 Szczygielski J, Mautes A, Steudel WI, Falkai P, Bayer TA, et al.

Traumatic brain injury: cause or risk of Alzheimer's disease? A review of experimental studies

JOURNAL OF NEURAL TRANSMISSION. 2005 NOV; 112 (11): 1547-1564

126

625

17443 Buneeva OA, Medvedev AE

Ubiquitin-protein ligase parkin and its role in the development of Parkinson's disease

BIOCHEMISTRY-MOSCOW. 2006 AUG; 71 (8): 851-860

104

626

17869 Julien JP, Kriz J

Transgenic mouse models of amyotrophic lateral sclerosis

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2006 NOV-DEC; 1762 (11-12): 1013-1024

129

627

18128 Ozansoy M, Basak AN

Tauopathies: A distinct class of neurodegenerative diseases

BALKAN JOURNAL OF MEDICAL GENETICS. 2007; 10 (2): 3-14

628

18775 Jellinger KA

The enigma of vascular cognitive disorder and vascular dementia

ACTA NEUROPATHOLOGICA. 2007 APR; 113 (4): 349-388

551

629

19168 Barry DM, Millecamps S, Julien JP, Garcia ML

New movements in neurofilament transport, turnover and disease

EXPERIMENTAL CELL RESEARCH. 2007 JUN 10; 313 (10): 2110-2120

104

630

19473 Leroy K, Bretteville A, Schindowski K, Gilissen E, Authelet M, et al.

Early axonopathy preceding neurofibrillary tangles in mutant tau transgenic mice

AMERICAN JOURNAL OF PATHOLOGY. 2007 SEP; 171 (3): 976-992

Date / Author / Journal

LCS

GCS

LCR

631

19929 Pankratz N, Foroud T

Genetics of Parkinson disease

GENETICS IN MEDICINE. 2007 DEC; 9 (12): 801-811

220

632

20295 Rohrer JD, Knight WD, Warren JE, Fox NC, Rossor MN, et al.

Word-finding difficulty: a clinical analysis of the progressive aphasias

BRAIN. 2008 JAN; 131: 8-38

215

633

21667 Fasano M, Alberio T, Lopiano L

Peripheral biomarkers of Parkinson's disease as early reporters of central neurodegeneration

BIOMARKERS IN MEDICINE. 2008 OCT; 2 (5): 465-478

135

634

22054 Zhou JH, Yu QM, Zou T

Alternative splicing of exon 10 in the tau gene as a target for treatment of tauopathies

BMC NEUROSCIENCE. 2008 DEC 3; 9: Art. No. S10

635

22671 Ludolph AC, Kassubek J, Landwehrmeyer BG, Mandelkow E, Mandelkow EM, et al.

Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options

EUROPEAN JOURNAL OF NEUROLOGY. 2009 MAR; 16 (3): 297-309

636

23175 Golovko MY, Barcelo-Coblijn G, Castagnet PI, Austin S, Combs CK, et al.

The role of alpha-synuclein in brain lipid metabolism: a downstream impact on brain inflammatory response

MOLECULAR AND CELLULAR BIOCHEMISTRY. 2009 JUN; 326 (1-2): 55-66

153

637

23242 Yotsumoto K, Saito T, Asada A, Oikawa T, Kimura T, et al.

Effect of Pin1 or Microtubule Binding on Dephosphorylation of FTDP-17 Mutant Tau

JOURNAL OF BIOLOGICAL CHEMISTRY. 2009 JUN 19; 284 (25): 16840-16847

638

23857 Paris I, Lozano J, Perez-Pastene C, Munoz P, Segura-Aguilar J

Molecular and Neurochemical Mechanisms in PD Pathogenesis

NEUROTOXICITY RESEARCH. 2009 OCT; 16 (3): 271-279

639

24139 Mistur R, Mosconi L, De Santi S, Guzman M, Li Y, et al.

Current Challenges for the Early Detection of Alzheimer's Disease: Brain Imaging and CSF Studies

JOURNAL OF CLINICAL NEUROLOGY. 2009 DEC; 5 (4): 153-166

153

640

25497 Obeso JA, Rodriguez-Oroz MC, Goetz CG, Marin C, Kordower JH, et al.

Missing pieces in the Parkinson's disease puzzle

NATURE MEDICINE. 2010 JUN; 16 (6): 653-661

126

Date / Author / Journal

641

Protein aggregation in Parkinson's disease

ACTA NEUROLOGICA SCANDINAVICA. 2010 JUL; 122: 82-87

642

25619 Feng LR, Federoff HJ, Vicini S, Maguire-Zeiss KA

alpha-Synuclein mediates alterations in membrane conductance: a potential role for alpha-synuclein oligomers in cell vulnerability

EUROPEAN JOURNAL OF NEUROSCIENCE. 2010 JUL; 32 (1): 10-17

643

25983 Dolan PJ, Johnson GVW

The role of tau kinases in Alzheimer's disease

CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT. 2010 SEP; 13 (5): 595-603

109

644

26147 Geser F, Robinson JL, Malunda JA, Xie SX, Clark CM, et al.

Pathological 43-kDa Transactivation Response DNA-Binding Protein in Older Adults With and Without Severe Mental Illness

ARCHIVES OF NEUROLOGY. 2010 OCT; 67 (10): 1238-1250

645

26640 Colodner KJ, Feany MB

Glial Fibrillary Tangles and JAK/STAT-Mediated Glial and Neuronal Cell Death in a Drosophila Model of Glial Tauopathy

JOURNAL OF NEUROSCIENCE. 2010 DEC 1; 30 (48): 16102-16113

646

6553 Hanger DP, Betts JC, Loviny TLF, Blackstock WP, Anderton BH

New phosphorylation sites identified in hyperphosphorylated tau (paired helical filament-tau) from Alzheimer's disease brain using nanoelectrospray mass spectrometry

JOURNAL OF NEUROCHEMISTRY. 1998 DEC; 71 (6): 2465-2476

124

173

647

7665 Spittaels K, Van den Haute C, Van Dorpe J, Bruynseels K, Vandezande K, et al.

Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein

AMERICAN JOURNAL OF PATHOLOGY. 1999 DEC; 155 (6): 2153-2165

173

197

648

10056 Perrin RJ, Woods WS, Clayton DF, George JM

Exposure to long chain polyunsaturated fatty acids triggers rapid multimerization of synucleins

JOURNAL OF BIOLOGICAL CHEMISTRY. 2001 NOV 9; 276 (45): 41958-41962

103

649

10286 Jellinger KA

Recent developments in the pathology of Parkinson's disease

JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT. 2002; (62): 347-376

169

650

11147 Weller RE, Steele GE, Kaas JH

Pulvinar and other subcortical connections of dorsolateral visual cortex in monkeys

JOURNAL OF COMPARATIVE NEUROLOGY. 2002 AUG 26; 450 (3): 215-240

283

Date / Author / Journal

LCS

GCS

LCR

651

11345 Skipper L, Farrer M

Parkinson's genetics: Molecular insights for the new millennium

NEUROTOXICOLOGY. 2002 OCT; 23 (4-5): 503-514

134

652

12151 Hardy J, Cookson MR, Singleton A

Genes and parkinsonism

LANCET NEUROLOGY. 2003 APR; 2 (4): 221-228

102

653

12278 Destee A

Neuroprotection and neurodegenerative parkinsonian syndromes.

REVUE NEUROLOGIQUE. 2003 MAY; 159 (5): S93-S104

156

654

12767 Di Rosa G, Puzzo D, Sant'Angelo A, Trinchese F, Arancio O

alpha-synuclein: between synaptic function and dysfunction

HISTOLOGY AND HISTOPATHOLOGY. 2003 OCT; 18 (4): 1257-1266

102

655

13475 Wersinger C, Vernier P, Sidhu A

Trypsin disrupts the trafficking of the human dopamine transporter by alpha-synuclein and its A30P mutant

BIOCHEMISTRY. 2004 FEB 10; 43 (5): 1242-1253

656

14046 Pountney DL, Lowe R, Quilty M, Vickers JC, Voelcker NH, et al.

Annular alpha-synuclein species from purified multiple system atrophy inclusions

JOURNAL OF NEUROCHEMISTRY. 2004 JUL; 90 (2): 502-512

657

14925 Harrison PJ, Weinberger DR

Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence

MOLECULAR PSYCHIATRY. 2005 JAN; 10 (1): 40-68

632

392

658

15010 Wenning GK, Jellinger KA

The role of alpha-synuclein in the pathogenesis of multiple system atrophy

ACTA NEUROPATHOLOGICA. 2005 FEB; 109 (2): 129-140

101

659

16443 Coimbra A, Williams DS, Hostetler ED

The role of MRI and PET/SPECT in Alzheimer's disease

CURRENT TOPICS IN MEDICINAL CHEMISTRY. 2006; 6 (6): 629-647

171

660

17185 McNaught KSP, Jackson T, JnoBaptiste R, Kapustin A, Olanow CW

Proteasomal dysfunction in sporadic Parkinson's disease

NEUROLOGY. 2006 MAY 23; 66 (10): S37-S49

104

Date / Author / Journal

LCS

GCS

LCR

661

17491 Wakabayashi K, Takahashi H

Cellular pathology in multiple system atrophy

NEUROPATHOLOGY. 2006 AUG; 26 (4): 338-345

662

19011 Zibaee S, Makin OS, Goedert M, Serpell LC

A simple algorithm locates beta-strands in the amyloid fibril core of alpha-synuclein, A beta, and tau using the amino acid sequence alone

PROTEIN SCIENCE. 2007 MAY; 16 (5): 906-918

112

663

19823 Mackenzie IRA, Rademakers R

The molecular genetics and neuropathology of frontotemporal lobar degeneration: recent developments

NEUROGENETICS. 2007 NOV; 8 (4): 237-248

664

20422 Mocanu MM, Nissen A, Eckermann K, Khlistunova I, Biernat J, et al.

The potential for beta-structure in the repeat domain of Tau protein determines aggregation, synaptic decay, neuronal loss, and coassembly with endogenous Tau in inducible mouse models of tauopathy

JOURNAL OF NEUROSCIENCE. 2008 JAN 16; 28 (3): 737-748

665

21448 Vosler PS, Brennan CS, Chen J

Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration

MOLECULAR NEUROBIOLOGY. 2008 AUG; 38 (1): 78-100

305

666

22019 de Bont JM, Packer RJ, Michiels EM, den Boer ML, Pieters R

Biological background of pediatric medulloblastoma and ependymoma: A review from a translational research perspective

NEURO-ONCOLOGY. 2008 DEC; 10 (6): 1040-1060

246

667

22063 Zhang L, Zhang CY, Zhu YY, Cai Q, Chan P, et al.

Semi-quantitative analysis of alpha-synuclein in subcellular pools of rat brain neurons: An immunogold electron microscopic study using a C- terminal specific monoclonal antibody

BRAIN RESEARCH. 2008 DEC 9; 1244: 40-52

668

22731 Hanger DP, Anderton BH, Noble W

Tau phosphorylation: the therapeutic challenge for neurodegenerative disease

TRENDS IN MOLECULAR MEDICINE. 2009 MAR; 15 (3): 112-119

669

22851 Koren J, Jinwal UK, Lee DC, Jones JR, Shults CL, et al.

Chaperone signalling complexes in Alzheimer's disease

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. 2009 APR; 13 (4): 619-630

133

670

23060 Zhou WB, Gallagher A, Hong DP, Long CM, Fink AL, et al.

At Low Concentrations, 3,4-Dihydroxyphenylacetic Acid (DOPAC) Binds Non-Covalently to alpha-Synuclein and Prevents Its Fibrillation

JOURNAL OF MOLECULAR BIOLOGY. 2009 MAY 8; 388 (3): 597-610

Date / Author / Journal

LCS

GCS

LCR

671

23152 Huang A, Stultz CM

Finding order within disorder: elucidating the structure of proteins associated with neurodegenerative disease

FUTURE MEDICINAL CHEMISTRY. 2009 JUN; 1 (3): 467-482

125

672

23236 Kowalska A

The genetics of dementias. Part 1: Molecular basis of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)

POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ. 2009 JUN 15; 63: 278-286

673

23806 McCormack AL, Di Monte DA

Enhanced alpha-Synuclein Expression in Human Neurodegenerative Diseases: Pathogenetic and Therapeutic Implications

CURRENT PROTEIN & PEPTIDE SCIENCE. 2009 OCT; 10 (5): 476-482

674

24754 Arawaka S, Machiya Y, Kato T

Heat Shock Proteins as Suppressors of Accumulation of Toxic Prefibrillar Intermediates and Misfolded Proteins in Neurodegenerative Diseases

CURRENT PHARMACEUTICAL BIOTECHNOLOGY. 2010 FEB; 11 (2): 158-166

675

25575 Urwin H, Josephs KA, Rohrer JD, Mackenzie IR, Neumann M, et al.

FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration

ACTA NEUROPATHOLOGICA. 2010 JUL; 120 (1): 33-41

676

26532 Viana RJS, Fonseca MB, Ramalho RM, Nunes AF, Rodrigues CMP

Organelle Stress Sensors and Cell Death Mechanisms in Neurodegenerative Diseases

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2010 DEC; 9 (6): 679-692

200

677

26564 Vanhelmont T, Vandebroek T, De Vos A, Terwel D, Lemaire K, et al.

Serine-409 phosphorylation and oxidative damage define aggregation of human protein tau in yeast

FEMS YEAST RESEARCH. 2010 DEC; 10 (8): 992-1005

678

26905 Prasad K, Tarasewicz E, Strickland PA, O'Neill M, Mitchell SN, et al.

Biochemical and morphological consequences of human alpha-synuclein expression in a mouse alpha-synuclein null background

EUROPEAN JOURNAL OF NEUROSCIENCE. 2011 FEB; 33 (4): 642-656

679

3641 GOEDERT M

MOLECULAR DISSECTION OF THE NEUROFIBRILLARY LESIONS OF ALZHEIMERS- DISEASE

ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH. 1995 MAR; 45-1 (3A): 403-409

680

5839 Zheng-Fischhofer QY, Biernat J, Mandelkow EM, Illenberger S, Godemann R, et al.

Sequential phosphorylation of Tau by glycogen synthase kinase-3 beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer- specific epitope of antibody AT100 and requires a paired-helical- filament-like conformation

EUROPEAN JOURNAL OF BIOCHEMISTRY. 1998 MAR 15; 252 (3): 542-552

117

166

Date / Author / Journal

LCS

GCS

LCR

681

6049 Illenberger S, Zheng-Fischhofer QY, Preuss U, Stamer K, Baumann K, et al.

The endogenous and cell cycle-dependent phosphorylation of tau protein in living cells: Implications for Alzheimer's disease

MOLECULAR BIOLOGY OF THE CELL. 1998 JUN; 9 (6): 1495-1512

101

159

102

682

7380 Kim D, Su J, Cotman CW

Sequence of neurodegeneration and accumulation of phosphorylated tau in cultured neurons after okadaic acid treatment

BRAIN RESEARCH. 1999 AUG 28; 839 (2): 253-262

683

9075 Lowe J, Mayer J, Landon M, Layfield R

Ubiquitin and the molecular pathology of neurodegenerative diseases

NEUROPATHOLOGY AND GENETICS OF DEMENTIA. 2001; 487: 169-186

144

684

9127 El-Agnaf OMA, Irvine GB

Aggregation and properties of alpha-synuclein and related proteins

SPECTROSCOPY-AN INTERNATIONAL JOURNAL. 2001; 15 (3-4): 141-150

685

9886 Neumann M, Schulz-Schaeffer W, Crowther RA, Smith MJ, Spillantini MG, et al.

Pick's disease associated with the novel Tau gene mutation K369I

ANNALS OF NEUROLOGY. 2001 OCT; 50 (4): 503-513

686

9961 Kins S, Crameri A, Evans DRH, Hemmings BA, Nitsch RM, et al.

Reduced protein phosphatase 2A activity induces hyperphosphorylation and altered compartmentalization of tau in transgenic mice

JOURNAL OF BIOLOGICAL CHEMISTRY. 2001 OCT 12; 276 (41): 38193-38200

687

10119 Giasson BI, Duda JE, Forman MS, Lee VMY, Trojanowski JQ

Prominent perikaryal expression of alpha- and beta-synuclein in neurons of dorsal root ganglion and in medullary neurons

EXPERIMENTAL NEUROLOGY. 2001 DEC; 172 (2): 354-362

688

10199 Jellinger KA

Recent developments in the pathology of Parkinson's disease

AGEING AND DEMENTIA CURRENT AND FUTURE CONCEPTS. 2002; : 347-376

167

689

10888 Greicius MD, Geschwind MD, Miller BL

Presenile dementia syndromes: an update on taxonomy and diagnosis

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2002 JUN; 72 (6): 691-700

170

690

11116 Higuchi M, Ishihara T, Zhang B, Hong M, Andreadis A, et al.

Transgenic mouse model of tauopathies with glial pathology and nervous system degeneration

NEURON. 2002 AUG 1; 35 (3): 433-446

Date / Author / Journal

691

Cerebrospinal fluid brain-derived proteins in the diagnosis of Alzheimer's disease and Creutzfeldt-Jakob disease

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2002 DEC; 28 (6): 427-440

135

692

11651 McNaught KS, Olanow CW

Proteolytic stress: A unifying concept for the etiopathogenesis of Parkinson's disease

ANNALS OF NEUROLOGY. 2003; 53: S73-S84

693

11722 Spillantini MG

Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17

INTERNATIONAL SEMINAR ON NUCLEAR WAR AND PLANETARY EMERGENCIES - 27TH SESSION. 2003; : 647-659

694

11965 Liou AKF, Clark RS, Henshall DC, Yin XM, Chen J

To die or not to die for neurons in ischemia, traumatic brain injury and epilepsy: a review on the stress-activated signaling pathways and apoptotic pathways

PROGRESS IN NEUROBIOLOGY. 2003 FEB; 69 (2): 103-142

497

695

13604 Lee VMY, Giasson BI, Trojanowski JQ

More than just two peas in a pod: common amyloidogenic properties of tau and alpha-synuclein in neurodegenerative diseases

TRENDS IN NEUROSCIENCES. 2004 MAR; 27 (3): 129-134

696

14003 Klucken J, Shin Y, Masliah E, Hyman BT, McLean PJ

Hsp70 reduces alpha-synuclein aggregation and toxicity

JOURNAL OF BIOLOGICAL CHEMISTRY. 2004 JUN 11; 279 (24): 25497-25502

113

139

697

14040 Rissman RA, Poon WW, Blurton-Jones M, Oddo S, Torp R, et al.

Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology

JOURNAL OF CLINICAL INVESTIGATION. 2004 JUL; 114 (1): 121-130

125

698

14337 Zhou Y, Gu GY, Goodlett DR, Zhang T, Pan C, et al.

Analysis of alpha-synuclein-associated proteins by quantitative proteomics

JOURNAL OF BIOLOGICAL CHEMISTRY. 2004 SEP 10; 279 (37): 39155-39164

699

14538 Fernagut PO, Chesselet MF

Alpha-synuclein and transgenic mouse models

NEUROBIOLOGY OF DISEASE. 2004 NOV; 17 (2): 123-130

700

15056 Cotman CW, Poon WW, Rissman RA, Blurton-Jones M

The role of caspase cleavage of tau in Alzheimer disease neuropathology

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2005 FEB; 64 (2): 104-112

Trojanowski w/citing papers Publications by JQ Trojanowski and the papers citing JQ Trojanowski	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 336329, GCS 1007154, CR 1762209 Collection span: 1973 - 2011
List of All Records